Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Biotech
Milestone resubmits NDA, Aldeyra readies 2nd chance filing
Milestone Pharmaceuticals has resubmitted a new drug application to the FDA, with Aldeyra readying a similar ask for the second half of the year.
Max Bayer
Mar 28, 2024 10:40am
GAO: FDA should audit hiring efforts to boost worker retention
Mar 27, 2024 4:15pm
FDA to ban electric shock devices for behavior control—again
Mar 27, 2024 11:49am
Medtronic nets FDA approval for evolved Evolut TAVR valve
Mar 27, 2024 10:06am
Neuronetics TMS nets first-line OK for depression in adolescents
Mar 26, 2024 11:02am
Nanoscope eyes market after phase 2b retinal disease data drop
Mar 26, 2024 7:00am